SEC Form D private-offering filing

Faeth Therapeutics, Inc.

Name: Faeth Therapeutics, Inc. - new SEC Form D private-offering filing, Austin, TX
Published: 2026-01-27

A new SEC Form D private-offering notice from Austin, TX, a $24,999,993 filer-stated offering target in Biotech. The source filing is one click away.

Faeth Therapeutics, Inc. site↗ Verified via SEC Form D

Clinical stage biotechnology company developing cancer metabolism therapies that combine precision nutrition with AI driven drug discovery, lead candidate PIKTOR targets the PI3K/AKT/mTOR pathway.

Filed 2026-01-27Filed to raise $24,999,993First money in 2025-08-01Raised so far $24,434,214HQ (as filed) Austin, TXSector Biotech ✓Stage (inferred) EarlyCall status Late filing

Source linked the Form D on EDGAR↗Website verified faeththerapeutics.com↗Named in the filing 6 executives & directors

Open this row on the live feed →More new filings in Texas →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.